Skip to main content
Article
Growth hormone treatment and adverse events in Prader-Willi syndrome: Data from KIGS (the Pfizer International Growth Database).
All Scholarly Works
  • Edward Reiter, MD, Baystate Health
Document Type
Article, Peer-reviewed
Publication Date
8-1-2006
Abstract
OBJECTIVE: To evaluate the response to recombinant GH treatment and adverse events in children with Prader-Willi syndrome (PWS) from KIGS, the Pfizer International Growth Database. PATIENTS: A total of 328 children (274 prepubertal, median age 6.0 years;
Publication ISSN
0884-8734
Citation Information
Clin Endocrinol (Oxf). 2006 Aug;65(2):178-85.